ERBB2 and neoplasm: It is notable that even transgenic models of forced cyclin D1a overexpression show quite limited capacity for tumor formation, which is latent, and requires co-expression of the Erbb2 oncogene for robust tumor induction in younger mice (Wang et al, 1994).